Sign In
Buy MED
$10.62
-0.400 (-3.63%)
At Close: Jun 23, 2026
The Schall Law Firm Is Investigating Medifast, Inc. And Seeks Investor Participation
11:00am, Friday, 16'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc.
Shareholders That Lost Money on Medifast, Inc. (MED) Should Contact Levi & Korsinsky About Securities Fraud Investigation - MED
10:55am, Friday, 16'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medifast, Inc. ("Medifast") (NYSE:MED) concerning possible violations of fed
The Schall Law Firm Is Opening An Investigation Into Medifast, Inc. And Encourages Investor Participation
07:00pm, Thursday, 15'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc.
The Schall Law Firm Announces An Investigation Into Claims Against Medifast, Inc. And Invites Investor Participation
07:15pm, Wednesday, 14'th Aug 2024
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for viol
Medifast (MED) Tumbles 25% in 3 Months: Should You Buy Now?
10:36am, Wednesday, 14'th Aug 2024
Medifast (MED) is encountering difficulties in attracting customers due to a reduction in the number of active OPTAVIA Coaches and diminished productivity per Coach.
Medifast (MED) Q2 Earnings Beat Estimates, Revenues Fall Y/Y
08:25am, Tuesday, 06'th Aug 2024
Medifast's (MED) Q2 results highlight the challenges of poor customer acquisition. However, the company is focusing strategically on medically supported weight loss, indicating potential for growth.
Medifast, Inc. (MED) Q2 2024 Earnings Call Transcript
09:55pm, Monday, 05'th Aug 2024
Medifast, Inc. (NYSE:MED ) Q2 2024 Earnings Conference Call August 5, 2024 4:30 PM ET Company Participants Steven Zenker - Vice President, Investor Relations Dan Chard - Chairman and Chief Executive O
Medifast (MED) Q2 Earnings and Revenues Beat Estimates
06:55pm, Monday, 05'th Aug 2024
Medifast (MED) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $2.77 per share a year ago.
Medifast Announces Second Quarter 2024 Financial Results
04:05pm, Monday, 05'th Aug 2024
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarte
Medifast (MED) Q2 Earnings in the Cards: Factors to Watch
10:21am, Friday, 02'nd Aug 2024
Medifast's (MED) Q2 results are likely to reflect customer acquisition challenges stemming from the growth of GLP-1 medications in markets.
Time to Unload: 3 Stocks in Deep Trouble to Sell Now
07:00am, Monday, 22'nd Jul 2024
The end of the pandemic served as a springboard for the economy, launching us into a new bull market. I can't blame people for being optimistic after seeing the meteoric rise of several big-name stock
7 Consumer Staples Stocks to Buy at a 52-Week Low in July
04:45pm, Friday, 19'th Jul 2024
For the last two years, investors in consumer staples stocks saw every tiny step forward smacked down by two large steps back. Therefore, the 900+-point gain in the Dow Jones Industrial Average (DJIA)
Medifast (MED) Lags Industry in 3 Months: How to Play Ahead?
10:35am, Tuesday, 16'th Jul 2024
While Medifast (MED) is implementing a series of measures to propel its growth trajectory, the challenges related to customer acquisition and high marketing expenses keep it in a tight spot.
Investor Participation Is Invited As The Schall Law Firm Announces An Investigation Into Claims Against Medifast, Inc.
12:00pm, Wednesday, 03'rd Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("M
Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025
06:50am, Friday, 28'th Jun 2024
Low-priced stocks to buy with the potential to double within the next year or so have inherent appeal for investors. Individual shares are affordable making it relatively easy to establish a stake.
